The protective role of SR-A in supporting microglial migration and Aβ phagocytosis helps limit plaque accumulation during the early stages of AD; however, its expression declines markedly as the disease progresses, which may contribute to reduced Aβ clearance in later stages [157,158,159,160]. Here, MSR1 is linked to Alzheimer disease.